Arnout Ploos van Amstel - 17 May 2024 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Reporting relationship: Director
Issuer ticker: ZURA
Reported as of: 17 May 2024
Net transaction value: +$496,000
SEC form: 4
Accepted by SEC: 23 May 2024, 08:53:36 UTC
Prior SEC filing: 26 Jan 2024
Next SEC filing: 11 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Arnout Ploos van Amstel

Key filing fact

Arnout Ploos van Amstel filed Form 4 for Zura Bio Ltd (ZURA) on 23 May 2024.

Key facts

This page summarizes Arnout Ploos van Amstel's Form 4 filing for Zura Bio Ltd (ZURA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 May 2024, 08:53.

Change

Previous filing in this sequence was filed on 26 Jan 2024.
Current net transaction value: +$496,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZURA transaction

Class A ordinary shares

Purchase

Transaction value: $496,000
Shares: +80,000
Change %: +400%
Price: $6.20
Shares after: 100,000
Date: 17 May 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $6.194848 to $6.199696 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.